Simudyne vs Ultramarin (2026)
Two vendors whose credibility is structural rather than published, built on opposite structures and at opposite ends of autonomy. Simudyne's structure is method: agent based simulators validated through a published six step process against observed statistical and behavioral dynamics, a technical guide, a public sandbox anyone can inspect, and a globally systemic bank that led the funding and described deploying the technology across credit, market and operational risk in its own words. Ultramarin's structure is supervision with skin in the game: a licensed asset management subsidiary supervised by BaFin since September 2024, running over a billion euros of the company's own money on the same platform it licenses to banks and intermediaries, with SFDR obligations named at the article level. On autonomy the two sit at opposite ends. Nothing in Simudyne's product decides or executes, because rehearsal is the point, and its residual exposure is the unvalidated passage from simulated conclusion to live threshold. Everything in Ultramarin's chain is automated through to the order reaching the market, with governance existing as client set boundaries rather than described oversight, plus an unanswered question about signal timing between its house funds and its clients. Neither publishes a result.
- Your question is systemic. Contagion, feedback, crowding and liquidity spirals emerge from simulated participants rather than being assumed, across credit, market, operational, fraud and financial crime applications.
- Your validation standard is published. A six step process ensures simulators reproduce observed dynamics, with a technical guide, a public sandbox and six doctorates behind it.
- Your reference is a systemic bank. It led the funding and described its own deployment across three risk disciplines, naming default contagion and stress testing as live uses.
- Your supplier should be licensed. The asset management subsidiary has been supervised by BaFin since September 2024, with over a billion euros running on the platform and SFDR obligations named at article level.
- Your intelligence should arrive in the wrapper you can hold. Funds, managed accounts, exchange traded products, structured products or direct access to the Ultrascope research interface on more than 2,000 companies.
- Your committee wants the vendor's own money at risk. The platform is proven by running the company's supervised funds at scale, not by a benchmark claim.
This comparison is published by AI FinTech Index, an independent research platform that publishes independent ratings of AI vendors for financial services. Simudyne and Ultramarin are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI FinTech Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Simudyne | Ultramarin | |
|---|---|---|
| Primary category | Capital Markets & Research AI | Capital Markets & Research AI |
| Founded | 2016 | 2017 |
| Headquarters | London, United Kingdom | Berlin, Germany |
| Website | simudyne.com | www.ultramarin.ai |
Side by Side
Select any grade to read the note behind it.
| Axis | S Simudyne |
U Ultramarin |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model Risk Management and Transparency | ||
| Operational and Outcome Evidence | ||
| AI Safety and Data Stewardship | ||
| GLBA and Data Privacy Posture | ||
| Security Certifications and Trust Center | ||
| Regulatory Status and Licensure | ||
| AI Governance and Bias Disclosure | ||
| AI Liability and Recourse | ||
| Model Supply Chain Disclosure | ||
| Core Systems and Integration Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Institution and Segment Coverage |
The short version of each
Simudyne
Simudyne validates its agent based simulators through a published six step process against observed statistical and behavioral dynamics. Behind it sit a technical guide, a public sandbox anyone can inspect, six doctorates on staff, and a globally systemic bank that led the funding and described deploying the technology across credit, market and operational risk in its own words. According to the AI FinTech Index, its validation method is documented in detail, and nothing in the product decides or executes, since rehearsal is the point. The residual exposures sit at the edges. The passage from simulated conclusion to live threshold, where rehearsal output tunes execution algorithms and fraud systems, carries no described validation between the two environments. No supervisory stress testing regime is named anywhere, despite the flagship use serving one. A published method is still not a performance figure, and no result is published.
Source: AI FinTech Index, 2026
Ultramarin
Ultramarin's credibility starts with supervision: an asset management subsidiary licensed and supervised by BaFin since September 2024, running over a billion euros of the company's own money on the same platform it licenses to banks and intermediaries, with SFDR obligations named at article level. According to the AI FinTech Index, supervision with skin in the game is credibility of a kind marketing cannot manufacture. On autonomy, everything in the chain is automated through to the order reaching the market, with no published checkpoint and governance existing as client set boundaries rather than described oversight. A sequencing question between the house funds and the clients consuming the same signals goes unanswered. No performance result, attestation or hosting arrangement is published beside the license.
Source: AI FinTech Index, 2026
Common questions
Do Simudyne and Ultramarin compete?
No. Simudyne sells simulation for rehearsing decisions, primarily to large banks across risk disciplines, while Ultramarin runs equity investment processes end to end for banks, family offices and intermediaries, so the buyer and the job differ entirely. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
How does each earn credibility without a track record?
Structurally, and differently. Simudyne publishes a six step validation methodology with a public sandbox, and Ultramarin operates under a BaFin license with over a billion euros of its own funds on the platform. Neither answers the missing track record with published results. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
How do the autonomy positions compare?
They sit at opposite ends. Nothing in Simudyne's system decides or executes, while Ultramarin automates through to execution with no published checkpoint. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
What does each leave unanswered?
Simudyne does not describe what validates simulation conclusions before they tune live execution and fraud thresholds. Ultramarin does not say where a human can intervene in the automated chain or how house fund and client signal timing is sequenced. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified August 23, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Capital Markets & Research AI page.
Both answer the missing track record with structure rather than published results, and the structures differ. Simudyne's answer is method: a validation process specified in six steps against observed reality and open to inspection through a sandbox. That is a strong model risk position and still not a performance figure. Ultramarin's answer is supervision and skin in the game: a license held since 2024 and over a billion euros of its own money on the platform.
That is a strong regulatory position and equally not a published result. Between them stretches the whole range of autonomy. Nothing in Simudyne's platform decides or executes anything, existing so decisions can be rehearsed, while Ultramarin automates the entire chain through execution with no published checkpoint. Each end carries its exposure. At Simudyne, rehearsal conclusions tune live thresholds with no described validation between the two environments.
At Ultramarin, governance is by client set boundary rather than described oversight, and the sequencing between its house funds and its Ultrascope interface clients goes unaddressed. Simudyne names no supervisory stress regime despite serving one, while Ultramarin names its regime at article level. Neither publishes an attestation, hosting arrangement, pricing or liability position.